InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn™ in Advance of Commercial Scale Production
5 g/L cannabinoid yield significantly exceeds reported industry yields Significantly reduces the overall cost of rare cannabinoid manufacturing Continued advancement to GMP-ready large-scale batch production Vancouver, BC – June 17, 2021… Read More




